| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1182: Finerenone for treating chronic heart failure with preserved or mildly reduced ejection fraction |
|
Medicine details |
|
| Medicine name | finerenone (Kerendia®) |
| Formulation | Oral |
| Reference number | 3184 |
| Indication | Treatment of symptomatic chronic heart failure with left ventricular ejection fraction (LVEF) for more than or equal to 40% in adults |
| Company | Bayer Plc |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 05/08/2026 |
| NICE guidance | |